Clinical Trial

Ex Vivo Evaluation on Human Tissue of the Binding of Experimental Radiolabeled Ligands

Study acronym: HERO
Recruiting
View on ClinicalTrials.gov →
Summary
The HERO project aims to structure an ex vivo screening platform, based on anonymized human tissues, to early assess the tissue fixation of experimental ligands in an ethical, translational approach that complies with the principles of the 3Rs (Replacement, Reduction, Refinement).
Trial Details
NCT Number NCT07047677
Lead Sponsor Central Hospital, Nancy, France
Conditions Tissue Model
Enrollment 300 participants
Start Date 2025-11-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2030-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04